Newstral
Vyondys
- BSarepta Stock Is Spiking as FDA Reverses Course, Approving Drugbarrons.com
- MSarepta stock surges more than 20% as FDA finally OKs muscular dystrophy drugmarketwatch.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.